Literature DB >> 22674535

Biallelic expression of Tbx1 protects the embryo from developmental defects caused by increased receptor tyrosine kinase signaling.

Subreena Simrick1, Dorota Szumska, Jennifer R Gardiner, Kieran Jones, Karun Sagar, Bernice Morrow, Shoumo Bhattacharya, M Albert Basson.   

Abstract

BACKGROUND: 22q11.2 deletion syndrome (22q11DS) is the most common microdeletion syndrome in humans, characterized by cardiovascular defects such as interrupted aortic arch, outflow tract defects, thymus and parathyroid hypo- or aplasia, and cleft palate. Heterozygosity of Tbx1, the mouse homolog of the candidate TBX1 gene, results in mild defects dependent on genetic background, whereas complete inactivation results in severe malformations in multiple tissues.
RESULTS: The loss of function of two Sprouty genes, which encode feedback antagonists of receptor tyrosine kinase (RTK) signaling, phenocopy many defects associated with 22q11DS in the mouse. The stepwise reduction of Sprouty gene dosage resulted in different phenotypes emerging at specific steps, suggesting that the threshold up to which a given developmental process can tolerate increased RTK signaling is different. Tbx1 heterozygosity significantly exacerbated the severity of all these defects, which correlated with a substantial increase in RTK signaling.
CONCLUSIONS: Our findings suggest that TBX1 functions as an essential component of a mechanism that protects the embryo against perturbations in RTK signaling that may lead to developmental defects characteristic of 22q11DS. We propose that genetic factors that enhance RTK signaling ought to be considered as potential genetic modifiers of this syndrome.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674535      PMCID: PMC4048740          DOI: 10.1002/dvdy.23812

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  69 in total

1.  Evaluation of potential modifiers of the palatal phenotype in the 22q11.2 deletion syndrome.

Authors:  Deborah A Driscoll; Torrey Boland; Beverly S Emanuel; Richard E Kirschner; Don LaRossa; Jeanne Manson; Donna McDonald-McGinn; Peter Randall; Cynthia Solot; Elaine Zackai; Laura E Mitchell
Journal:  Cleft Palate Craniofac J       Date:  2006-07

2.  BMPs and FGFs target Notch signalling via jagged 2 to regulate tooth morphogenesis and cytodifferentiation.

Authors:  Thimios A Mitsiadis; Daniel Graf; Hansueli Luder; Thomas Gridley; Gilles Bluteau
Journal:  Development       Date:  2010-08-04       Impact factor: 6.868

3.  Sprouty2 controls proliferation of palate mesenchymal cells via fibroblast growth factor signaling.

Authors:  Kaori Matsumura; Takaharu Taketomi; Keigo Yoshizaki; Shinsaku Arai; Terukazu Sanui; Daigo Yoshiga; Akihiko Yoshimura; Seiji Nakamura
Journal:  Biochem Biophys Res Commun       Date:  2010-12-30       Impact factor: 3.575

4.  Genetic factors are major determinants of phenotypic variability in a mouse model of the DiGeorge/del22q11 syndromes.

Authors:  I Taddei; M Morishima; T Huynh; E A Lindsay
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

5.  Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome.

Authors:  P J Scambler; A H Carey; R K Wyse; S Roach; J P Dumanski; M Nordenskjold; R Williamson
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

6.  Fgf8 expression in the Tbx1 domain causes skeletal abnormalities and modifies the aortic arch but not the outflow tract phenotype of Tbx1 mutants.

Authors:  Francesca Vitelli; Zhen Zhang; Tuong Huynh; Angela Sobotka; Annalisa Mupo; Antonio Baldini
Journal:  Dev Biol       Date:  2006-04-04       Impact factor: 3.582

7.  Tbx1 is regulated by tissue-specific forkhead proteins through a common Sonic hedgehog-responsive enhancer.

Authors:  Hiroyuki Yamagishi; Jun Maeda; Tonghuan Hu; John McAnally; Simon J Conway; Tsutomu Kume; Erik N Meyers; Chihiro Yamagishi; Deepak Srivastava
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

8.  VEGF: a modifier of the del22q11 (DiGeorge) syndrome?

Authors:  Ingeborg Stalmans; Diether Lambrechts; Frederik De Smet; Sandra Jansen; Jian Wang; Sunit Maity; Paige Kneer; Maren von der Ohe; Ann Swillen; Christa Maes; Marc Gewillig; Daniel G M Molin; Peter Hellings; Thurid Boetel; Maartin Haardt; Veerle Compernolle; Mieke Dewerchin; Stephane Plaisance; Robert Vlietinck; Beverly Emanuel; Adriana C Gittenberger-de Groot; Peter Scambler; Bernice Morrow; Deborah A Driscol; Lieve Moons; Camila V Esguerra; Geert Carmeliet; Annett Behn-Krappa; Koen Devriendt; Désiré Collen; Simon J Conway; Peter Carmeliet
Journal:  Nat Med       Date:  2003-01-21       Impact factor: 53.440

Review 9.  Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes.

Authors:  Lisa J Kobrynski; Kathleen E Sullivan
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

10.  Sprouty genes are essential for the normal development of epibranchial ganglia in the mouse embryo.

Authors:  Subreena Simrick; Heiko Lickert; M Albert Basson
Journal:  Dev Biol       Date:  2011-07-23       Impact factor: 3.582

View more
  5 in total

1.  Importance of endothelial Hey1 expression for thoracic great vessel development and its distal enhancer for Notch-dependent endothelial transcription.

Authors:  Yusuke Watanabe; Daiki Seya; Dai Ihara; Shuhei Ishii; Taiki Uemoto; Atsushi Kubo; Yuji Arai; Yoshie Isomoto; Atsushi Nakano; Takaya Abe; Mayo Shigeta; Teruhisa Kawamura; Yoshihiko Saito; Toshihiko Ogura; Osamu Nakagawa
Journal:  J Biol Chem       Date:  2020-10-16       Impact factor: 5.157

Review 2.  DNA methylation and differentiation: silencing, upregulation and modulation of gene expression.

Authors:  Melanie Ehrlich; Michelle Lacey
Journal:  Epigenomics       Date:  2013       Impact factor: 4.778

3.  Early de novo DNA methylation and prolonged demethylation in the muscle lineage.

Authors:  Koji Tsumagari; Carl Baribault; Jolyon Terragni; Katherine E Varley; Jason Gertz; Sirharsa Pradhan; Melody Badoo; Charlene M Crain; Lingyun Song; Gregory E Crawford; Richard M Myers; Michelle Lacey; Melanie Ehrlich
Journal:  Epigenetics       Date:  2013-02-15       Impact factor: 4.528

4.  Importance of endothelial Hey1 expression for thoracic great vessel development and its distal enhancer for Notch-dependent endothelial transcription.

Authors:  Yusuke Watanabe; Daiki Seya; Dai Ihara; Shuhei Ishii; Taiki Uemoto; Atsushi Kubo; Yuji Arai; Yoshie Isomoto; Atsushi Nakano; Takaya Abe; Mayo Shigeta; Teruhisa Kawamura; Yoshihiko Saito; Toshihiko Ogura; Osamu Nakagawa
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

5.  Endoderm-specific deletion of Tbx1 reveals an FGF-independent role for Tbx1 in pharyngeal apparatus morphogenesis.

Authors:  Abigail Jackson; Sahrunizam Kasah; Suzanne L Mansour; Bernice Morrow; M Albert Basson
Journal:  Dev Dyn       Date:  2014-06-12       Impact factor: 3.780

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.